logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
P

Paul H. Sugarbaker

washington cancer institute

114H-index
914Paper Count
4.6WCitation Count
Published Papers 149
Publication Date
logo
PREOPERATIVE TUMOR MARKER ELEVATIONS IN LYMPH NODE POSITIVE APPENDICEAL MUCINOUS NEOPLASMS WITH PERITONEAL METASTASES
errEuropean Journal of Surgical Oncology
IF2.9
err2025-11-21
err0
PREAI
errPaul H. Sugarbaker; David Chang
errShare
errSave
Preoperative tumor marker elevations in colorectal cancer patients with peritoneal metastases should be used to help select patients for cytoreductive surgery
errEJSO
IF2.9
err2025-06-01
err0
PREAI
errGhabra, Shadin; Chang, David; Sugarbaker, Paul H.
errShare
errSave
Severe postoperative pancreatitis following treatment of peritoneal metastases
errEJSO
IF2.9
err2025-05-01
err0
PREAI
errSugarbaker, Paul H.
errShare
errSave
Cellularity of mucus is a prognostic variable in low-grade appendiceal mucinous neoplasms
errEJSO
IF2.9
err2024-07-01
err3
PREAI
errSugarbaker, Paul H.; Liang, John J.; Deng, Tom; Chang, David
errShare
errSave
It Is What the Surgeon Does Not See That Kills the Patient
errJOURNAL OF CLINICAL MEDICINE
IF2.9
err2024-04-12
err1
errOAAI
errSugarbaker, Paul H.
errShare
errSave
A narrative review of what can HIPEC do
errEJSO
IF2.9
err2023-09-01
err10
PREAI
errSugarbaker, Paul H.
errShare
errSave
Pathogenesis of histologic variations of appendiceal mucinous neoplasms
errEJSO
IF2.9
err2023-05-01
err4
PREAI
errSugarbaker, Paul H.; Chang, David; Liang, John
errShare
errSave
Clinical and Histopathologic Features of 35 Patients Treated for Colorectal Peritoneal Metastases Who Survived 5 Years
errDISEASES OF THE COLON & RECTUM
IF3.7
err2023-02-28
err7
PREAI
errGhabra, Shadin; Desale, Sameer; Sugarbaker, Paul H.
errShare
errSave
Similar Survival Among All Subtypes of Mucinous Appendiceal Adenocarcinoma Except the Intermediate Subtype, Which Shows an Improved Survival
errANNALS OF SURGICAL ONCOLOGY
IF3.5
err2022-12-21
err10
PREAI
errSugarbaker, Paul H.; Chang, David; Liang, John J.
errShare
errSave
ASO Author Reflections: Similar Survival of All Subtypes of Mucinous Appendiceal Adenocarcinoma Except the Intermediate Subtype Which Shows an Improved Survival
errANNALS OF SURGICAL ONCOLOGY
IF3.5
err2022-12-08
err0
PREAI
errSugarbaker, Paul H.; Chang, David; Liang, John J.
errShare
errSave
Lymph node positive pseudomyxoma peritonei
errEJSO
IF2.9
err2022-12-01
err6
PREAI
errSugarbaker, Paul H.; Chang, David
errShare
errSave
Peritoneal metastases from colorectal cancer in the absence of lymph node metastases show a high survival rate despite unfavorable prognostic indicators
errEJSO
IF2.9
err2022-07-01
err5
PREAI
errSugarbaker, Paul H.; Chang, David
errShare
errSave
Anatomic sites of disease in colorectal cancer patients recorded at the time of cytoreductive surgery for peritoneal metastases
errEJSO
IF2.9
err2022-05-01
err11
PREAI
errSugarbaker, Paul H.; Chang, David
errShare
errSave
The impact of PRODIGE 7 on the current worldwide practice of CRS-HIPEC for colorectal peritoneal metastases: A web-based survey and 2021 statement by Peritoneal Surface Oncology Group International (PSOGI)
errEJSO
IF2.9
err2021-11-01
err33
PREAI
errvan de Vlasakker, Vincent C. J.; Lurvink, Robin J.; Cashin, Peter H.; Ceelen, Wim; Deraco, Marcello; Goere, Diane; Gonzalez-Moreno, Santiago; Lehmann, Kuno; Li, Yan; Moran, Brendan; Morris, David L.; Piso, Pompiliu; Quadros, Claudio A.; Rau, Beate; Somashekhar, S. P.; Sommariva, Antonio; van der Speeten, Kurt; Spiliotis, John; Sugarbaker, Paul H.; Teo, Melissa C. C.; Verwaal, Vic J.; Yonemura, Yutaka; Glehen, Olivier; de Hingh, Ignace H. J. T.
errShare
errSave
Concerning CT features predict outcome of treatment in patients with malignant peritoneal mesothelioma
errEJSO
IF2.9
err2021-09-01
err14
PREAI
errSugarbaker, Paul H.; Chang, David; Jelinek, James S.
errShare
errSave
Appendiceal tumors with glandular and neuroendocrine features exhibiting peritoneal metastases-Critical evaluation of outcome following cytoreductive surgery with perioperative chemotherapy
errEJSO
IF2.9
err2021-06-01
err6
PREAI
errBarrak, Dany; Desale, Sameer; Yoon, JaeHee J.; Dugan, Michelle M.; Kodavanti, Preeti Prasad; Sampah, Maame Efua; Sugarbaker, Paul H.
errShare
errSave
Cytoreductive Surgery Plus HIPEC With and Without NIPEC for Malignant Peritoneal Mesothelioma: A Propensity-Matched Analysis
errANNALS OF SURGICAL ONCOLOGY
IF3.5
err2021-05-03
err18
PREAI
errSugarbaker, Paul H.; Chang, David
errShare
errSave
ASO Author Reflections: Normothermic Intraperitoneal Chemotherapy Long-Term for Malignant Peritoneal Mesothelioma
errANNALS OF SURGICAL ONCOLOGY
IF3.5
err2021-04-28
err0
PREAI
errSugarbaker, Paul H.
errShare
errSave
Prevention and Treatment of Peritoneal Metastases from Gastric Cancer
errJOURNAL OF CLINICAL MEDICINE
IF2.9
err2021-04-28
err11
errOAAI
errSugarbaker, Paul H.
errShare
errSave
Colorectal cancer cells from patients treated with FOLFOX or CAPOX are resistant to oxaliplatin
errEJSO
IF2.9
err2021-04-01
err45
PREAI
errNagourney, Robert A.; Evans, Steven; Tran, Peter H.; Nagourney, Adam J.; Sugarbaker, Paul H.
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
P
Paolo Boffetta
H-index: 167 · Papers: 2.1K
H
Harvey I. Pass
H-index: 153 · Papers: 1.4K
E
Ernest E. Moore
H-index: 153 · Papers: 2.8K
H
Herbert J. Zeh
H-index: 109 · Papers: 818
F
Frederick A. Moore
H-index: 104 · Papers: 1.0K
View more